Teng C S, Tong T C, Hutchison J H, Yeung R T
Arch Dis Child. 1980 Nov;55(11):894-5. doi: 10.1136/adc.55.11.894.
Two patients with neonatal Graves's disease are reported. One of them had a delayed onset because of suppression of the fetal thyroid gland by antithyroid drug taken by the mother during pregnancy. Thyroid-stimulating immunoglobulins (TSAb), measured by a receptor assay, were present in both babies when they were thyrotoxic, and also in their mothers. TSAb were undetectable in both babies 1 year after birth. This strongly supports a pathogenetic role of TSAb in this condition through transplacental transfer of maternal TSAb.
本文报告了两例新生儿格雷夫斯病患者。其中一例发病延迟,原因是母亲在孕期服用抗甲状腺药物抑制了胎儿甲状腺。通过受体分析测定,两名婴儿在发生甲状腺毒症时均存在甲状腺刺激免疫球蛋白(TSAb),其母亲体内也有。两名婴儿在出生1年后均检测不到TSAb。这有力地支持了TSAb通过母体TSAb经胎盘转移在该病发病机制中所起的作用。